Infectious balanitis: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Vishal (talk | contribs)
nocaptcha
1,461 edits
No edit summary
Vishal (talk | contribs)
nocaptcha
1,461 edits
Line 23: Line 23:
!Virulence factors  
!Virulence factors  
|-
|-
|Candidal Balanitis
|[[Candidiasis|Candidal Balanitis]]
|
|
* Sexual transmitted
* Sexual transmitted
* Normal flora
* Opportunistic infection
|
|
* Diabetes
* [[Diabetes]]
* Immunocompromised
* [[Immunocompromised]]
* Age>40 yrs
* Age>40 yrs
|
|
Line 45: Line 45:
* Tight foreskin
* Tight foreskin
* sub-optimal hygienic maintenance
* sub-optimal hygienic maintenance
|Anaerobic gram-negative rods produce various [[toxins]], [[proteases]], elastase, and other virulence factors
|[[Anaerobic]] [[Gram-negative bacilli|gram-negative rods]] produce various [[toxins]], [[proteases]], [[elastase]], and other [[virulence factors]]
|-
|-
|Aerobic
|[[Aerobic organism|Aerobic]]
Infections
[[Aerobic organism|Infections]]
|Sexually transmitted
|
Autoinoculation from other sites  
* [[Sexually transmitted]]
* [[Autoinoculation]] from other sites  
|
|
* Uncircumcised penis
* Uncircumcised penis


* Diabetes
* [[Diabetes]]
* Immunocompromised   
* [[Immunocompromised]]  
|Adherence to epithelial cells, biofilm production, surface hydrophobicity, phospholipase C and protease activity
|Adherence to [[epithelial cells]], [[Biofilm|biofilm production]], surface hydrophobicity, [[phospholipase C]] and [[protease]] activity
|-
|-
|Trichomonas vaginalis
|[[Trichomonas vaginalis]]
|Sexually transmitted  
|[[Sexually transmitted]]
|
|
* Multiple sexual partners
* Multiple sexual partners
* Unprotected sexual activity
* Unprotected sexual activity
* Co-existing [[venereal diseases]]
* Co-existing [[venereal diseases]]
|Virulence factors such as adherence, contact-independent factors, hemolysis and acquisition of host macromolecules have been shown to play a role in the pathogenesis of this infection
|[[Virulence factors]] such as adherence, contact-independent factors, [[hemolysis]] and acquisition of host [[macromolecules]] have been shown to play a role in the pathogenesis of this infection
|-
|-
|Treponema  
|[[Treponema pallidum|Treponema]]
pallidum
[[Treponema pallidum|pallidum]]
|Transmitted via direct contact with the infected lesion (sexual contact)
|Transmitted via direct contact with the infected lesion (sexual contact)
|Risk factors include:<ref name="pmid2356911">{{cite journal| author=Rolfs RT, Goldberg M, Sharrar RG| title=Risk factors for syphilis: cocaine use and prostitution. | journal=Am J Public Health | year= 1990 | volume= 80 | issue= 7 | pages= 853-7 | pmid=2356911 | doi= | pmc=1404975 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2356911  }}</ref><ref name="pmid17675391">{{cite journal| author=Zhou H, Chen XS, Hong FC, Pan P, Yang F, Cai YM et al.| title=Risk factors for syphilis infection among pregnant women: results of a case-control study in Shenzhen, China. | journal=Sex Transm Infect | year= 2007 | volume= 83 | issue= 6 | pages= 476-80 | pmid=17675391 | doi=10.1136/sti.2007.026187 | pmc=2598725 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17675391  }}</ref><ref name="pmid15247352">{{cite journal| author=Hook EW, Peeling RW| title=Syphilis control--a continuing challenge. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 2 | pages= 122-4 | pmid=15247352 | doi=10.1056/NEJMp048126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15247352  }}</ref><ref name="pmid16205297">{{cite journal| author=Buchacz K, Greenberg A, Onorato I, Janssen R| title=Syphilis epidemics and human immunodeficiency virus (HIV) incidence among men who have sex with men in the United States: implications for HIV prevention. | journal=Sex Transm Dis | year= 2005 | volume= 32 | issue= 10 Suppl | pages= S73-9 | pmid=16205297 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16205297  }}</ref><ref name="pmid25514173">{{cite journal| author=Solomon MM, Mayer KH| title=Evolution of the syphilis epidemic among men who have sex with men. | journal=Sex Health | year= 2015 | volume= 12 | issue= 2 | pages= 96-102 | pmid=25514173 | doi=10.1071/SH14173 | pmc=4470884 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25514173  }}</ref><ref name="pmid24927712">{{cite journal| author=Hakre S, Arteaga GB, Núñez AE, Arambu N, Aumakhan B, Liu M et al.| title=Prevalence of HIV, syphilis, and other sexually transmitted infections among MSM from three cities in Panama. | journal=J Urban Health | year= 2014 | volume= 91 | issue= 4 | pages= 793-808 | pmid=24927712 | doi=10.1007/s11524-014-9885-4 | pmc=4134449 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24927712  }}</ref><ref name="newell">Newell, J., et al. "A population-based study of syphilis and sexually transmitted disease syndromes in north-western Tanzania. 2. Risk factors and health seeking behaviour." Genitourinary medicine 69.6 (1993): 421-426.</ref>
|[[Risk factors]] include:<ref name="pmid2356911">{{cite journal| author=Rolfs RT, Goldberg M, Sharrar RG| title=Risk factors for syphilis: cocaine use and prostitution. | journal=Am J Public Health | year= 1990 | volume= 80 | issue= 7 | pages= 853-7 | pmid=2356911 | doi= | pmc=1404975 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2356911  }}</ref><ref name="pmid17675391">{{cite journal| author=Zhou H, Chen XS, Hong FC, Pan P, Yang F, Cai YM et al.| title=Risk factors for syphilis infection among pregnant women: results of a case-control study in Shenzhen, China. | journal=Sex Transm Infect | year= 2007 | volume= 83 | issue= 6 | pages= 476-80 | pmid=17675391 | doi=10.1136/sti.2007.026187 | pmc=2598725 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17675391  }}</ref><ref name="pmid15247352">{{cite journal| author=Hook EW, Peeling RW| title=Syphilis control--a continuing challenge. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 2 | pages= 122-4 | pmid=15247352 | doi=10.1056/NEJMp048126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15247352  }}</ref><ref name="pmid16205297">{{cite journal| author=Buchacz K, Greenberg A, Onorato I, Janssen R| title=Syphilis epidemics and human immunodeficiency virus (HIV) incidence among men who have sex with men in the United States: implications for HIV prevention. | journal=Sex Transm Dis | year= 2005 | volume= 32 | issue= 10 Suppl | pages= S73-9 | pmid=16205297 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16205297  }}</ref><ref name="pmid25514173">{{cite journal| author=Solomon MM, Mayer KH| title=Evolution of the syphilis epidemic among men who have sex with men. | journal=Sex Health | year= 2015 | volume= 12 | issue= 2 | pages= 96-102 | pmid=25514173 | doi=10.1071/SH14173 | pmc=4470884 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25514173  }}</ref><ref name="pmid24927712">{{cite journal| author=Hakre S, Arteaga GB, Núñez AE, Arambu N, Aumakhan B, Liu M et al.| title=Prevalence of HIV, syphilis, and other sexually transmitted infections among MSM from three cities in Panama. | journal=J Urban Health | year= 2014 | volume= 91 | issue= 4 | pages= 793-808 | pmid=24927712 | doi=10.1007/s11524-014-9885-4 | pmc=4134449 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24927712  }}</ref><ref name="newell">Newell, J., et al. "A population-based study of syphilis and sexually transmitted disease syndromes in north-western Tanzania. 2. Risk factors and health seeking behaviour." Genitourinary medicine 69.6 (1993): 421-426.</ref>


Multiple sexual partners, prostitution, Illicit drug use, unprotected sex
Multiple sexual partners, prostitution, Illicit drug use, unprotected sex
Line 76: Line 77:
|Treponema Pallidum uses [[fibronectin]] molecules to attach to the [[endothelial]] surface of the vessels in organs resulting in inflammation and obliteration of the small blood vessels causing [[vasculitis]] ([[endarteritis obliterans]])
|Treponema Pallidum uses [[fibronectin]] molecules to attach to the [[endothelial]] surface of the vessels in organs resulting in inflammation and obliteration of the small blood vessels causing [[vasculitis]] ([[endarteritis obliterans]])
|-
|-
|Herpes simplex
|[[Herpes simplex]]
|Often transmitted sexually
|Often transmitted sexually


Direct contact with, or droplets from, infected secretions entering via skin or mucous membrane
direct contact with, or droplets from, infected secretions entering via skin or mucous membrane
|Multiple sexual partners  
|
 
* Multiple sexual partners
Low socio-economic status  
* Low socio-economic status  
|Inhibition of MHC Class I, Impairing funtion of dentric cells  
|Inhibition of [[MHC class I|MHC Class I]], Impairing funtion of [[Dendritic cell|dendritric cells]]
|-
|-
|Human papilloma virus
|[[Human papilloma virus]]
|Usually transmitted via the sexual route to the human host. 
|Usually transmitted via the sexual route to the human host. 
|Risk factors responsible for sexual transmission of HPV include:
|Risk factors responsible for sexual transmission of HPV include:
Line 92: Line 93:


,Having non monogamous sex partner<ref name="pmid9217656">{{cite journal |vauthors=Koutsky L |title=Epidemiology of genital human papillomavirus infection |journal=Am. J. Med. |volume=102 |issue=5A |pages=3–8 |year=1997 |pmid=9217656 |doi= |url=}}</ref><ref name="pmid12543621">{{cite journal |vauthors=Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA |title=Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students |journal=Am. J. Epidemiol. |volume=157 |issue=3 |pages=218–26 |year=2003 |pmid=12543621 |doi= |url=}}</ref>, Starting sexual activity in young age<ref name="pmid9217656">{{cite journal |vauthors=Koutsky L |title=Epidemiology of genital human papillomavirus infection |journal=Am. J. Med. |volume=102 |issue=5A |pages=3–8 |year=1997 |pmid=9217656 |doi= |url=}}</ref>,Vaginal delivery and multiple deliveries<ref name="pmid9464728">{{cite journal |vauthors=Tseng CJ, Liang CC, Soong YK, Pao CC |title=Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery |journal=Obstet Gynecol |volume=91 |issue=1 |pages=92–6 |year=1998 |pmid=9464728 |doi= |url=}}</ref>, Age over 40 for women<ref name="pmid21495248">{{cite journal |vauthors=Ting J, Kruzikas DT, Smith JS |title=A global review of age-specific and overall prevalence of cervical lesions |journal=Int. J. Gynecol. Cancer |volume=20 |issue=7 |pages=1244–9 |year=2010 |pmid=21495248 |doi= |url=}}</ref>, History of [[Chlamydia infection|Chlamydia]] infection<ref name="pmid9332762">{{cite journal |vauthors=Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ |title=Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? |journal=Cancer Epidemiol. Biomarkers Prev. |volume=6 |issue=10 |pages=799–805 |year=1997 |pmid=9332762 |doi= |url=}}</ref>, Long term [[Oral contraceptive|OCP]] use<ref name="pmid1649312">{{cite journal |vauthors=Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, Manos MM |title=Determinants of genital human papillomavirus infection in young women |journal=J. Natl. Cancer Inst. |volume=83 |issue=14 |pages=997–1003 |year=1991 |pmid=1649312 |doi= |url=}}</ref>
,Having non monogamous sex partner<ref name="pmid9217656">{{cite journal |vauthors=Koutsky L |title=Epidemiology of genital human papillomavirus infection |journal=Am. J. Med. |volume=102 |issue=5A |pages=3–8 |year=1997 |pmid=9217656 |doi= |url=}}</ref><ref name="pmid12543621">{{cite journal |vauthors=Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA |title=Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students |journal=Am. J. Epidemiol. |volume=157 |issue=3 |pages=218–26 |year=2003 |pmid=12543621 |doi= |url=}}</ref>, Starting sexual activity in young age<ref name="pmid9217656">{{cite journal |vauthors=Koutsky L |title=Epidemiology of genital human papillomavirus infection |journal=Am. J. Med. |volume=102 |issue=5A |pages=3–8 |year=1997 |pmid=9217656 |doi= |url=}}</ref>,Vaginal delivery and multiple deliveries<ref name="pmid9464728">{{cite journal |vauthors=Tseng CJ, Liang CC, Soong YK, Pao CC |title=Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery |journal=Obstet Gynecol |volume=91 |issue=1 |pages=92–6 |year=1998 |pmid=9464728 |doi= |url=}}</ref>, Age over 40 for women<ref name="pmid21495248">{{cite journal |vauthors=Ting J, Kruzikas DT, Smith JS |title=A global review of age-specific and overall prevalence of cervical lesions |journal=Int. J. Gynecol. Cancer |volume=20 |issue=7 |pages=1244–9 |year=2010 |pmid=21495248 |doi= |url=}}</ref>, History of [[Chlamydia infection|Chlamydia]] infection<ref name="pmid9332762">{{cite journal |vauthors=Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ |title=Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? |journal=Cancer Epidemiol. Biomarkers Prev. |volume=6 |issue=10 |pages=799–805 |year=1997 |pmid=9332762 |doi= |url=}}</ref>, Long term [[Oral contraceptive|OCP]] use<ref name="pmid1649312">{{cite journal |vauthors=Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, Manos MM |title=Determinants of genital human papillomavirus infection in young women |journal=J. Natl. Cancer Inst. |volume=83 |issue=14 |pages=997–1003 |year=1991 |pmid=1649312 |doi= |url=}}</ref>
|linked to epithelial [[differentiation]] and maturation of host keratinocytes, with [[transcription]] of specific gene products at every level.<sup>[[Human papillomavirus pathophysiology|[2][3]]]</sup>
|linked to [[epithelial]] [[differentiation]] and maturation of host [[keratinocytes]], with [[transcription]] of specific [[Gene|gene products]] at every level.<sup>[[Human papillomavirus pathophysiology|[2][3]]]</sup>
|}
|}


Line 109: Line 110:
{{familytree/end}}
{{familytree/end}}


==Epidemiology and Demographics==
==Epidemiology ==


==== Epidemiology ====
==== Epidemiology ====
There are no comprehensive studies, studying the incidence and prevalence in general population. Studies have showed that Balanitis commonly occurs around 10% of the patient population visiting the STD clinc, with infectious etiology responsible for around 50% of the cases.<ref name="pmid8707315">{{cite journal| author=Edwards S| title=Balanitis and balanoposthitis: a review. | journal=Genitourin Med | year= 1996 | volume= 72 | issue= 3 | pages= 155-9 | pmid=8707315 | doi= | pmc=1195642 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8707315  }}</ref>  
* There are no comprehensive studies, studying the [[incidence]] and [[prevalence]] in general population. Studies have showed that Balanitis commonly occurs around 10% of the patient population visiting the [[STD]] clinc, with [[infectious]] etiology responsible for around 50% of the cases.<ref name="pmid8707315">{{cite journal| author=Edwards S| title=Balanitis and balanoposthitis: a review. | journal=Genitourin Med | year= 1996 | volume= 72 | issue= 3 | pages= 155-9 | pmid=8707315 | doi= | pmc=1195642 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8707315  }}</ref>
 
* [[Candidiasis|Candida]] being the most common cause responsible for 30-35% of cases.<ref name="pmid8566986">{{cite journal| author=Dockerty WG, Sonnex C| title=Candidal balano-posthitis: a study of diagnostic methods. | journal=Genitourin Med | year= 1995 | volume= 71 | issue= 6 | pages= 407-9 | pmid=8566986 | doi= | pmc=1196117 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8566986  }}</ref>
Candida being the most common cause responsible for 30-35% of cases.<ref name="pmid8566986">{{cite journal| author=Dockerty WG, Sonnex C| title=Candidal balano-posthitis: a study of diagnostic methods. | journal=Genitourin Med | year= 1995 | volume= 71 | issue= 6 | pages= 407-9 | pmid=8566986 | doi= | pmc=1196117 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8566986  }}</ref>
 
==== Demographics ====


==Screening==
==Screening==
There is no established screening guidelines for Infectious Balanitis
There is no established screening guidelines for Infectious Balanitis.


==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==
===Natural history===
===Natural history===
If left untreated, Infection balanitis may result in complications.<ref name="pmid248285532">{{cite journal| author=Edwards SK, Bunker CB, Ziller F, van der Meijden WI| title=2013 European guideline for the management of balanoposthitis. | journal=Int J STD AIDS | year= 2014 | volume= 25 | issue= 9 | pages= 615-26 | pmid=24828553 | doi=10.1177/0956462414533099 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24828553  }}</ref>
If left untreated, Infectious balanitis may result in complications.<ref name="pmid248285532">{{cite journal| author=Edwards SK, Bunker CB, Ziller F, van der Meijden WI| title=2013 European guideline for the management of balanoposthitis. | journal=Int J STD AIDS | year= 2014 | volume= 25 | issue= 9 | pages= 615-26 | pmid=24828553 | doi=10.1177/0956462414533099 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24828553  }}</ref>


===Complications===
===Complications===
Complication of Infectious balanitis include:<ref name="pmid24828553">{{cite journal| author=Edwards SK, Bunker CB, Ziller F, van der Meijden WI| title=2013 European guideline for the management of balanoposthitis. | journal=Int J STD AIDS | year= 2014 | volume= 25 | issue= 9 | pages= 615-26 | pmid=24828553 | doi=10.1177/0956462414533099 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24828553  }}</ref>
Complication of Infectious balanitis include:<ref name="pmid24828553">{{cite journal| author=Edwards SK, Bunker CB, Ziller F, van der Meijden WI| title=2013 European guideline for the management of balanoposthitis. | journal=Int J STD AIDS | year= 2014 | volume= 25 | issue= 9 | pages= 615-26 | pmid=24828553 | doi=10.1177/0956462414533099 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24828553  }}</ref>
* Pain
* [[Pain]]
* Erosions
* Erosions
* Fissures
* [[Fissures]]


* Phimosis
* [[Phimosis]]
* Paraphimosis
* [[Paraphimosis]]
* Painful erection
* Painful [[erection]]
* Reduced urinary flow
* Reduced urinary flow
* Urinary retention
* [[Urinary retention]]


===Prognosis===
===Prognosis===
Prognosis is good with treatment.  
[[Prognosis]] is good with treatment.  


==Diagnosis==
==Diagnosis==


==== History and symptoms ====
==== History and symptoms ====
Patients may be asymptomatic or present with pruritic, or painful lesions in the genital region.
Patients may be asymptomatic or present with [[Itch|pruritic]], or painful lesions in the [[Genital area|genital region]].
{| class="wikitable"
{| class="wikitable"
! colspan="2" |Clinical features of Infectious balanitis<ref name="pmid26396455">{{cite journal| author=Pandya I, Shinojia M, Vadukul D, Marfatia YS| title=Approach to balanitis/balanoposthitis: Current guidelines. | journal=Indian J Sex Transm Dis | year= 2014 | volume= 35 | issue= 2 | pages= 155-7 | pmid=26396455 | doi=10.4103/0253-7184.142415 | pmc=4553848 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26396455  }} </ref>(adopted from the Indian journal of sexually transmitted diseases and AIDS)
! colspan="2" |Clinical features of Infectious balanitis<ref name="pmid26396455">{{cite journal| author=Pandya I, Shinojia M, Vadukul D, Marfatia YS| title=Approach to balanitis/balanoposthitis: Current guidelines. | journal=Indian J Sex Transm Dis | year= 2014 | volume= 35 | issue= 2 | pages= 155-7 | pmid=26396455 | doi=10.4103/0253-7184.142415 | pmc=4553848 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26396455  }} </ref>(adopted from the Indian journal of sexually transmitted diseases and AIDS)
|-
|-
|Candidal Balanitis
|[[Candidiasis|Candidal Balanitis]]
|Erythematous rash with soreness and/or itch, blotchy erythema with small papules which may be eroded, or dry dull red areas with a glazed appearance
|[[Erythematous]] [[Rash (patient information)|rash]] with soreness and/or [[itch]], blotchy [[erythema]] with small [[papules]] which may be eroded, or dry dull red areas with a glazed appearance
|-
|-
|Anaerobic Infection
|[[Anaerobic organism|Anaerobic Infection]]
|Foul smelling sub-preputial inflammation and discharg: in severe cases associated with swelling and inflamed inguinal lymph nodes
|Foul smelling sub-preputial [[inflammation]] and [[discharge]]: in severe cases associated with [[swelling]] and inflamed [[inguinal lymph nodes]]
Preputial edema, superficial erosions: milder forms also occur
Preputial edema, superficial erosions: milder forms also occur
|-
|-
|Aerobic
|[[Aerobic organism|Aerobic]]
Infections
[[Aerobic organism|Infections]]
|Variable inflammatory changes including uniform erythema and edema
|Variable [[inflammatory]] changes including uniform [[erythema]] and [[edema]]
|-
|-
|Trichomonas  vaginalis
|[[Trichomonas vaginalis|Trichomonas  vaginalis]]
|Superficial erosive balanitis which may lead to phimosis
|Superficial erosive [[balanitis]] which may lead to [[phimosis]]
|-
|-
|Treponema paliidum
|[[Treponema pallidum]]
|Multiple circinate lesions which erode to cause irregular ulcers have been described in the late primary or early secondary stage. A primary chancre may also be present
|Multiple circinate lesions which erode to cause irregular [[ulcers]] have been described in the late primary or early secondary stage. A [[Chancre|primary chancre]] may also be present
|-
|-
|Herpes simplex
|[[Herpes simplex]]
|Grouped vesicles on erythematous base over glans, prepuce and shaft which rupture to form shallow erosins. In rare cases primary herpes can cause a necrotic balanitis, with necrotic areas on the glans accompained by vesicles elsewhere and associated with headache and malaise.
|Grouped [[vesicles]] on [[erythematous]] base over [[Glans penis|glans]], prepuce and shaft which rupture to form shallow erosins. In rare cases primary herpes can cause a necrotic balanitis, with necrotic areas on the glans accompained by vesicles elsewhere and associated with headache and malaise.
|-
|-
|Human papilloma virus
|[[Human papilloma virus]]
|Papilloma virus may be associated with patchy or chronic balanitis, which becomes acetowhite after the application of 5% acetic acid
|[[Human papillomavirus|Papilloma virus]] may be associated with patchy or chronic [[balanitis]], which becomes acetowhite after the application of 5% [[acetic acid]]
|}
|}
====Laboratory findings====
====Laboratory findings====
Line 174: Line 172:
! colspan="2" |Laboratory findings<ref name="pmid26396455">{{cite journal| author=Pandya I, Shinojia M, Vadukul D, Marfatia YS| title=Approach to balanitis/balanoposthitis: Current guidelines. | journal=Indian J Sex Transm Dis | year= 2014 | volume= 35 | issue= 2 | pages= 155-7 | pmid=26396455 | doi=10.4103/0253-7184.142415 | pmc=4553848 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26396455  }} </ref>(adopted from the Indian journal of sexually transmitted diseases and AIDS)
! colspan="2" |Laboratory findings<ref name="pmid26396455">{{cite journal| author=Pandya I, Shinojia M, Vadukul D, Marfatia YS| title=Approach to balanitis/balanoposthitis: Current guidelines. | journal=Indian J Sex Transm Dis | year= 2014 | volume= 35 | issue= 2 | pages= 155-7 | pmid=26396455 | doi=10.4103/0253-7184.142415 | pmc=4553848 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26396455  }} </ref>(adopted from the Indian journal of sexually transmitted diseases and AIDS)
|-
|-
|Candidal Balanitis
|[[Candidiasis|Candidal Balanitis]]
|Urinalysis for glucose
|[[Urinalysis]] for [[glucose]]
Sub-preputial culture/swab for primary candidasis/candidal superinfection-to be done in all cases
Sub-preputial culture/swab for [[Candidiasis|primary candidiasis/]][[candidal]] superinfection-to be done in all cases


Investigation for HIV or other causes of immunosuppression
Investigation for [[Human Immunodeficiency Virus|HIV]] or other causes of [[immunosuppression]]
|-
|-
|Anaerobic Infection
|[[Anaerobic organism|Anaerobic Infection]]
|
|
*Gram stain may show fusiform/mixed bacterial picture
*[[Gram stain]] may show fusiform/mixed [[bacterial]] picture
*Sub-preputial culture wet prep or NAAt(to exclude other causes)
*Sub-preputial culture wet prep or [[Nucleic acid test|NAAT]](to exclude other causes)
*G. vaginalis is a facultative anaerobe which may be isolated
*[[Gardnerella vaginalis|G. vaginalis]] is a [[facultative anaerobe]] which may be isolated
*Swab for HSV infection if ulcerated
*Swab for [[Herpes simplex virus|HSV]] infection if [[Ulcer|ulcerated]]
|-
|-
|Aerobic
|[[Aerobic organism|Aerobic]]
Infections
[[Aerobic organism|Infections]]
|Sub-preputial culture
|Sub-preputial culture
Streptococci spp. and S. aureus have both been reported as causing balanitis
[[Streptococci|Streptococci spp]]. and [[Staphylococcus aureus|S. aureus]] have both been reported as causing balanitis
|-
|-
|T. vaginalis
|[[Trichomonas vaginalis|Trichomonas  vaginalis]]
|Wet preparation from the subpreputial sac demonstrates the organism
|Wet preparation from the subpreputial sac demonstrates the organism
Culture and NAAT can also be carried out
[[Culture collection|Culture]] and [[NAAT]] can also be carried out
|-
|-
|TP
|[[Treponema pallidum]]
|Dark field microscopy, TP NAAT and DFA-TP will confirm the diagnosis. This should ideally be done every case.
|[[Dark field microscopy]], TP [[NAAT]] and [[DFA-TP]] will confirm the [[diagnosis]]. This should ideally be done every case.
TPHA coupled with nontreponemal serological tests though of limited value, should be performed since they are useful for follow-up
[[Treponema pallidum hemagglutination assay (TPHA) test|TPHA]] coupled with nontreponemal [[Serology|serological]] tests though of limited value, should be performed since they are useful for follow-up
|-
|-
|Herpes simplex
|[[Herpes simplex]]
|Tissue scraping from base of erosion subjected to Tzanck smear IgG and IgM for HSV cell culture and PCR-preferred HSV tests for persons who seek medical treatment for gential ulcers or other mucocutaneous lesions
|Tissue scraping from base of erosion subjected to [[Tzanck test|Tzanck smear]] [[IgG]] and [[IgM]] for [[HSV]] cell culture and [[PCR]]-preferred [[HSV]] tests for persons who seek medical treatment for [[Genital ulcer disease|gential ulcers]] or other [[mucocutaneous]] lesions
|-
|-
|Human papilloma virus
|[[Human papillomavirus|Human papilloma virus]]
|Diagnosed clinically
|Diagnosed clinically
|}
|}
Line 215: Line 213:
!Alternative regimen
!Alternative regimen
|-
|-
|Candidal Balanitis
|[[Candidiasis|Candidal Balanitis]]
|Clotimazole cream 1%
|[[Clotrimazole|Clotrimazole cream]] 1%
Miconazole cream 2%
[[Miconazole|Miconazole cream]] 2%
|Fluconazole 150 mg stat orally
|Fluconazole 150 mg stat orally
Nystatin cream-if resistance suspected topical clotrimazole/miconazole with 1% hydrocortisone-if marked inflammation
Nystatin cream-if resistance suspected topical clotrimazole/miconazole with 1% hydrocortisone-if marked inflammation
|-
|-
|Anaerobic Infection
|[[Anaerobic organism|Anaerobic Infection]]
|Advice about genital hygiene
|Advice about genital hygiene
metronidazole 400 mg twice daily for 1 week
[[metronidazole]] 400 mg twice daily for 1 week


Milder cases- topical metronidazole
Milder cases- topical metronidazole
Line 229: Line 227:
Clindamycin cream applied twice daily until resolved
Clindamycin cream applied twice daily until resolved
|-
|-
|Aerobic
|[[Aerobic organism|Aerobic]]
Infections
[[Aerobic organism|Infections]]
|Usually topical
|Usually topical
Triple combination (clotrimazole 1%, beclometasone dipropionate 0.025%, gentamicinsilfate 0.3%) applied once daily
Triple combination ([[clotrimazole]] 1%, [[Beclometasone dipropionate (nasal)|beclometasone dipropionate]] 0.025%, gentamicinsilfate 0.3%) applied once daily


Severe cases-systemic antibiotics
Severe cases-systemic antibiotics


Erythromycin 500 mg QDS for 1 week
[[Erythromycin]] 500 mg QDS for 1 week


Co-amoxiclav(amoxycillin/clvulanic acid 375 mg 3 times daily for 1 week
Co-amoxiclav(amoxycillin/clvulanic acid 375 mg 3 times daily for 1 week
|Alternative regimens depend on the sensitivities of the organisms isolated
|Alternative regimens depend on the sensitivities of the organisms isolated
|-
|-
|T. vaginalis
|[[Trichomonas vaginalis|Trichomonas  vaginalis]]
|Metronidazole 2 g orally single dose
|[[Metronidazole]] 2 g orally single dose
Secidazole 2 g orally single dose
Secidazole 2 g orally single dose
|Metronidazole 400 mg orally twice a day for 7 days
|Metronidazole 400 mg orally twice a day for 7 days
|-
|-
|TP
|[[Treponema pallidum]]
|Single IM administration of 2.4 MU of benzathine penicillin
|Single IM administration of 2.4 MU of [[Benzathine penicillin G|benzathine penicillin]]
Doxycycline 100 mg orally BID for 2 weeks or
[[Doxycycline]] 100 mg orally BID for 2 weeks or


Tetracycline 500 mg orally QID for 2 weeks or
[[Tetracycline]] 500 mg orally QID for 2 weeks or


Erythromycin 500 mg QID or
[[Erythromycin]] 500 mg QID or


Ceftriaxone 1 g IM/IV daily for 8-10 days
[[Ceftriaxone]] 1 g IM/IV daily for 8-10 days
|
|
|-
|-
|Herpes simplex
|[[Herpes simplex]]
|Acyclovir 400 mg orally 3 times a day for 7-10 days or
|[[Acyclovir]] 400 mg orally 3 times a day for 7-10 days or
Acyclovir 200 mg orally 5 times a day for 7-10 days or
[[Acyclovir]] 200 mg orally 5 times a day for 7-10 days or


Famciclovir 250 mg orally 3 times a day for 7-10 days or
[[Famciclovir]] 250 mg orally 3 times a day for 7-10 days or


Valacyclovir 1 g orally twice a day for 7-10 days
[[Valacyclovir]] 1 g orally twice a day for 7-10 days
|
|
|-
|-
|Human papilloma virus
|[[Human papillomavirus|Human papilloma virus]]
|Patients applied
|Patients applied
Podophyllotoxin(podofilox) 0.5% or gel-twice daily for three consecutive days, but no more than 4 weeks or Imiquimod 5% cream-applied at bedtime 3 times/week for a maximum of 16 weeks, and must be left in place for 6-10 h following application or Sinecatechins 15% ointment
[[Podophyllotoxin]](podofilox) 0.5% or gel-twice daily for three consecutive days, but no more than 4 weeks or Imiquimod 5% cream-applied at bedtime 3 times/week for a maximum of 16 weeks, and must be left in place for 6-10 h following application or [[Sinecatechins]] 15% ointment


Provider-administered
Provider-administered


Podophyllin resin 20% in a compound tincture
[[Podophyllin]] resin 20% in a compound tincture


of benzoin-once a week for 6-8 week or
of [[benzoin]]-once a week for 6-8 week or


Cryotherapy with liquid nitrogen ot cryoprobe.
[[Cryotherapy]] with liquid nitrogen ot cryoprobe.


Repeat applications every 1-2 weeks or
Repeat applications every 1-2 weeks or
Line 282: Line 280:
TCA/bichloroacetic acid-80-90% once per week for an average course of 6-10 weeks or
TCA/bichloroacetic acid-80-90% once per week for an average course of 6-10 weeks or


Surgical removal either by tangential scissor excision, tangential shave excision, curettage, or electrosurgery.
Surgical removal either by tangential scissor excision, tangential shave excision, [[curettage]], or [[electrosurgery]].
|
|
|}
|}
Line 288: Line 286:
==Prevention==
==Prevention==
===Primary Prevention===
===Primary Prevention===
Primary prevention of Infectious balanitis include:
[[Primary prevention]] of Infectious balanitis include:
 
* Safe sex practices.
Safe sex practices.
* Maintaining proper penile hygiene.
 
Maintaining proper penile hygiene.


===Secondary prevention===
===Secondary prevention===
There ares no specific secondary preventive measures for Infective balanitis.
There are no specific [[Secondary prevention|secondary preventive]] measures for Infective balanitis.


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 20:24, 8 February 2017


WikiDoc Resources for Infectious balanitis

Articles

Most recent articles on Infectious balanitis

Most cited articles on Infectious balanitis

Review articles on Infectious balanitis

Articles on Infectious balanitis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Infectious balanitis

Images of Infectious balanitis

Photos of Infectious balanitis

Podcasts & MP3s on Infectious balanitis

Videos on Infectious balanitis

Evidence Based Medicine

Cochrane Collaboration on Infectious balanitis

Bandolier on Infectious balanitis

TRIP on Infectious balanitis

Clinical Trials

Ongoing Trials on Infectious balanitis at Clinical Trials.gov

Trial results on Infectious balanitis

Clinical Trials on Infectious balanitis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Infectious balanitis

NICE Guidance on Infectious balanitis

NHS PRODIGY Guidance

FDA on Infectious balanitis

CDC on Infectious balanitis

Books

Books on Infectious balanitis

News

Infectious balanitis in the news

Be alerted to news on Infectious balanitis

News trends on Infectious balanitis

Commentary

Blogs on Infectious balanitis

Definitions

Definitions of Infectious balanitis

Patient Resources / Community

Patient resources on Infectious balanitis

Discussion groups on Infectious balanitis

Patient Handouts on Infectious balanitis

Directions to Hospitals Treating Infectious balanitis

Risk calculators and risk factors for Infectious balanitis

Healthcare Provider Resources

Symptoms of Infectious balanitis

Causes & Risk Factors for Infectious balanitis

Diagnostic studies for Infectious balanitis

Treatment of Infectious balanitis

Continuing Medical Education (CME)

CME Programs on Infectious balanitis

International

Infectious balanitis en Espanol

Infectious balanitis en Francais

Business

Infectious balanitis in the Marketplace

Patents on Infectious balanitis

Experimental / Informatics

List of terms related to Infectious balanitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]

Synonyms and keywords:Candida balanitis, Candidal balanitis, Infectious balanoposthitis

Overview

Balanitis is inflammation of glans penis, whenever balanitis involves foreskin and perpuce, it is termed as balanoposthitis. Studies have showed that Balanitis commonly occurs around 10% of the patient population visiting the STD clinc, with infectious etiology responsible for around 50% of the cases. Risk factors for balanitis include Diabetes, Immunocompromised, Age>40 yrs,tight foreskin, sub-optimal hygienic maintenance, Multiple sexual partners, and Uncircumcised penis. Orgnaism could be part of the normal flora or transmitted by sexually, or autoinoculation, or via direct contact. Patients may be asymptomatic or present with pruritic, or painful lesions in the genital region. Specific infectious balanitis etiology is diagnosed based on clinical presentation supported with laboratory findings. Infectious balanitis is usually treated with antimicrobials. Prognosis is usually good with treatment. Safe sex practices and maintaining proper penile hygiene are helpful in preventing Infective balanitis.

Historical Perspective

Balanitis is an ancient disease,The term Balanitis is derived from a Greek term balanos or acorn.

Classification

There is no established classification system for Infectious Balanitis.

Pathophysiology

Pathophysiology of Infectious balanitis varies from pathogen to pathogen:[1][2][3][4][5][6][7]

Pathogen Route of transmission Risk factors Virulence factors
Candidal Balanitis
  • Sexual transmitted
  • Opportunistic infection
  • All strains of C. albicans possess a yeast surface mannoprotein. This allows the various strains to adhere to both the exfoliated and buccal epithelial cells of the vagina.
  • Several virulence factors of Candida are implicated in Balanitis. These include proteolytic enzymes, toxins and phospholipase. Proteolytic enzymes destroy the proteins that normally impair fungal invasion
Anaerobic Infection

.

  • Tight foreskin
  • sub-optimal hygienic maintenance
 Anaerobic gram-negative rods produce various toxins, proteases, elastase, and other virulence factors
Aerobic

Infections

  • Uncircumcised penis
 Adherence to epithelial cells, biofilm production, surface hydrophobicity, phospholipase C and protease activity
Trichomonas vaginalis Sexually transmitted Virulence factors such as adherence, contact-independent factors, hemolysis and acquisition of host macromolecules have been shown to play a role in the pathogenesis of this infection
Treponema

pallidum

Transmitted via direct contact with the infected lesion (sexual contact) Risk factors include:[8][9][10][11][12][13][14]

Multiple sexual partners, prostitution, Illicit drug use, unprotected sex

men who have sex with men, residence in highly prevalent areas, HIV infection, presence of other STIs, previous history of STIs, Intravenous drug use, health care professionals who are predisposed to occupational risk, and Low socioeconomic status.

Treponema Pallidum uses fibronectin molecules to attach to the endothelial surface of the vessels in organs resulting in inflammation and obliteration of the small blood vessels causing vasculitis (endarteritis obliterans)
Herpes simplex Often transmitted sexually

direct contact with, or droplets from, infected secretions entering via skin or mucous membrane

  • Multiple sexual partners
  • Low socio-economic status
 Inhibition of MHC Class I, Impairing funtion of dendritric cells
Human papilloma virus Usually transmitted via the sexual route to the human host.  Risk factors responsible for sexual transmission of HPV include:

Number of sex partners[15][16],Acqusition of new partner[15]

,Having non monogamous sex partner[17][18], Starting sexual activity in young age[17],Vaginal delivery and multiple deliveries[19], Age over 40 for women[20], History of Chlamydia infection[21], Long term OCP use[22]

linked to epithelial differentiation and maturation of host keratinocytes, with transcription of specific gene products at every level.[2][3]

Causes

Causes of Infectious balanitis include:[23][24][5][25]

 
 
 
 
 
 
Balanitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fungal
 
Virus
 
Parasite/Protozoal
 
 
 
 
Bacteria
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Candida (albicans, krusei)
Dermatophytosis
Pityriasis versicolor
Histoplasma capsulatum
Blastomyces dermatitidis
Cryptococcus neoformans
 
Herpes simplex virus
Varicella zoster virus (VZV)
Human papilloma virus (HPV)
 
Protozoal
Entamoeba histolytica
Trichomonas vaginalis
Leishmania species
Parastic
Sarcoptes scabiei var hominis
Pediculosis
Ankylostoma species
 
Gram negative bacteria
E.coli, Pseudomonas, Haemophilus parainfluenzae, Klebsiella, Neisseria gonorrhoea, Haemophilus ducreyi, Mycoplasma genitalium, Chlamydia, Ureaplasma, Gardnerella vaginalis, Citrobacter, Enterobacter
 
Spirochaetes
Treponema pallidum, Non specific spirochaetal infection
 
Gram positive organism
Haemolytic Streptococci(Group B Streptococci), Staphylococci epidermidis/aureus
 
Acid fast bacilli
Mycobacterium tuberculosis, Leprosy
Anaerobes
(Bacteroides)
 

Epidemiology

Epidemiology

  • There are no comprehensive studies, studying the incidence and prevalence in general population. Studies have showed that Balanitis commonly occurs around 10% of the patient population visiting the STD clinc, with infectious etiology responsible for around 50% of the cases.[26]
  • Candida being the most common cause responsible for 30-35% of cases.[27]

Screening

There is no established screening guidelines for Infectious Balanitis.

Natural History, Complications, and Prognosis

Natural history

If left untreated, Infectious balanitis may result in complications.[5]

Complications

Complication of Infectious balanitis include:[28]

Prognosis

Prognosis is good with treatment.

Diagnosis

History and symptoms

Patients may be asymptomatic or present with pruritic, or painful lesions in the genital region.

Clinical features of Infectious balanitis[25](adopted from the Indian journal of sexually transmitted diseases and AIDS)
Candidal Balanitis Erythematous rash with soreness and/or itch, blotchy erythema with small papules which may be eroded, or dry dull red areas with a glazed appearance
Anaerobic Infection Foul smelling sub-preputial inflammation and discharge: in severe cases associated with swelling and inflamed inguinal lymph nodes

Preputial edema, superficial erosions: milder forms also occur

Aerobic

Infections

Variable inflammatory changes including uniform erythema and edema
Trichomonas vaginalis Superficial erosive balanitis which may lead to phimosis
Treponema pallidum Multiple circinate lesions which erode to cause irregular ulcers have been described in the late primary or early secondary stage. A primary chancre may also be present
Herpes simplex Grouped vesicles on erythematous base over glans, prepuce and shaft which rupture to form shallow erosins. In rare cases primary herpes can cause a necrotic balanitis, with necrotic areas on the glans accompained by vesicles elsewhere and associated with headache and malaise.
Human papilloma virus Papilloma virus may be associated with patchy or chronic balanitis, which becomes acetowhite after the application of 5% acetic acid

Laboratory findings

Laboratory findings[25](adopted from the Indian journal of sexually transmitted diseases and AIDS)
Candidal Balanitis Urinalysis for glucose

Sub-preputial culture/swab for primary candidiasis/candidal superinfection-to be done in all cases

Investigation for HIV or other causes of immunosuppression

Anaerobic Infection
Aerobic

Infections

Sub-preputial culture

Streptococci spp. and S. aureus have both been reported as causing balanitis

Trichomonas vaginalis Wet preparation from the subpreputial sac demonstrates the organism

Culture and NAAT can also be carried out

Treponema pallidum Dark field microscopy, TP NAAT and DFA-TP will confirm the diagnosis. This should ideally be done every case.

TPHA coupled with nontreponemal serological tests though of limited value, should be performed since they are useful for follow-up

Herpes simplex Tissue scraping from base of erosion subjected to Tzanck smear IgG and IgM for HSV cell culture and PCR-preferred HSV tests for persons who seek medical treatment for gential ulcers or other mucocutaneous lesions
Human papilloma virus Diagnosed clinically

Treatment

Treatment[25](adopted from the Indian journal of sexually transmitted diseases and AIDS)
Preferred regimen Alternative regimen
Candidal Balanitis Clotrimazole cream 1%

Miconazole cream 2%

Fluconazole 150 mg stat orally

Nystatin cream-if resistance suspected topical clotrimazole/miconazole with 1% hydrocortisone-if marked inflammation

Anaerobic Infection Advice about genital hygiene

metronidazole 400 mg twice daily for 1 week

Milder cases- topical metronidazole

Coamoxiclav(amoxycillin/clavulanic acid) 375 mg 3 times daily for 1 week

Clindamycin cream applied twice daily until resolved

Aerobic

Infections

Usually topical

Triple combination (clotrimazole 1%, beclometasone dipropionate 0.025%, gentamicinsilfate 0.3%) applied once daily

Severe cases-systemic antibiotics

Erythromycin 500 mg QDS for 1 week

Co-amoxiclav(amoxycillin/clvulanic acid 375 mg 3 times daily for 1 week

Alternative regimens depend on the sensitivities of the organisms isolated
Trichomonas vaginalis Metronidazole 2 g orally single dose

Secidazole 2 g orally single dose

Metronidazole 400 mg orally twice a day for 7 days
Treponema pallidum Single IM administration of 2.4 MU of benzathine penicillin

Doxycycline 100 mg orally BID for 2 weeks or

Tetracycline 500 mg orally QID for 2 weeks or

Erythromycin 500 mg QID or

Ceftriaxone 1 g IM/IV daily for 8-10 days

Herpes simplex Acyclovir 400 mg orally 3 times a day for 7-10 days or

Acyclovir 200 mg orally 5 times a day for 7-10 days or

Famciclovir 250 mg orally 3 times a day for 7-10 days or

Valacyclovir 1 g orally twice a day for 7-10 days

Human papilloma virus Patients applied

Podophyllotoxin(podofilox) 0.5% or gel-twice daily for three consecutive days, but no more than 4 weeks or Imiquimod 5% cream-applied at bedtime 3 times/week for a maximum of 16 weeks, and must be left in place for 6-10 h following application or Sinecatechins 15% ointment

Provider-administered

Podophyllin resin 20% in a compound tincture

of benzoin-once a week for 6-8 week or

Cryotherapy with liquid nitrogen ot cryoprobe.

Repeat applications every 1-2 weeks or

TCA/bichloroacetic acid-80-90% once per week for an average course of 6-10 weeks or

Surgical removal either by tangential scissor excision, tangential shave excision, curettage, or electrosurgery.

Prevention

Primary Prevention

Primary prevention of Infectious balanitis include:

  • Safe sex practices.
  • Maintaining proper penile hygiene.

Secondary prevention

There are no specific secondary preventive measures for Infective balanitis.

References

  1. ↑ Taylor PK, Rodin P (1975). "Herpes genitalis and circumcision". Br J Vener Dis. 51 (4): 274–7. PMC 1046564. PMID 1156848.
  2. ↑ Cree GE, Willis AT, Phillips KD, Brazier JS (1982). "Anaerobic balanoposthitis". Br Med J (Clin Res Ed). 284 (6319): 859–60. PMC 1496281. PMID 6121604.
  3. ↑ GENITOURINARY MEDICINE, Volume 72, Number 3: Pages 155-9,
  4. ↑ Lisboa C, Santos A, Dias C, Azevedo F, Pina-Vaz C, Rodrigues A (2010). "Candida balanitis: risk factors". J Eur Acad Dermatol Venereol. 24 (7): 820–6. doi:10.1111/j.1468-3083.2009.03533.x. PMID 20002652.
  5. ↑ 5.0 5.1 5.2 Edwards SK, Bunker CB, Ziller F, van der Meijden WI (2014). "2013 European guideline for the management of balanoposthitis". Int J STD AIDS. 25 (9): 615–26. doi:10.1177/0956462414533099. PMID 24828553.
  6. ↑ Hernandez BY, Wilkens LR, Zhu X, Thompson P, McDuffie K, Shvetsov YB; et al. (2008). "Transmission of human papillomavirus in heterosexual couples". Emerg Infect Dis. 14 (6): 888–94. doi:10.3201/eid1406.070616. PMC 2600292. PMID 18507898.
  7. ↑ Sobel JD (1985). "Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis". Am. J. Obstet. Gynecol. 152 (7 Pt 2): 924–35. PMID 3895958.
  8. ↑ Rolfs RT, Goldberg M, Sharrar RG (1990). "Risk factors for syphilis: cocaine use and prostitution". Am J Public Health. 80 (7): 853–7. PMC 1404975. PMID 2356911.
  9. ↑ Zhou H, Chen XS, Hong FC, Pan P, Yang F, Cai YM; et al. (2007). "Risk factors for syphilis infection among pregnant women: results of a case-control study in Shenzhen, China". Sex Transm Infect. 83 (6): 476–80. doi:10.1136/sti.2007.026187. PMC 2598725. PMID 17675391.
  10. ↑ Hook EW, Peeling RW (2004). "Syphilis control--a continuing challenge". N Engl J Med. 351 (2): 122–4. doi:10.1056/NEJMp048126. PMID 15247352.
  11. ↑ Buchacz K, Greenberg A, Onorato I, Janssen R (2005). "Syphilis epidemics and human immunodeficiency virus (HIV) incidence among men who have sex with men in the United States: implications for HIV prevention". Sex Transm Dis. 32 (10 Suppl): S73–9. PMID 16205297.
  12. ↑ Solomon MM, Mayer KH (2015). "Evolution of the syphilis epidemic among men who have sex with men". Sex Health. 12 (2): 96–102. doi:10.1071/SH14173. PMC 4470884. PMID 25514173.
  13. ↑ Hakre S, Arteaga GB, Núñez AE, Arambu N, Aumakhan B, Liu M; et al. (2014). "Prevalence of HIV, syphilis, and other sexually transmitted infections among MSM from three cities in Panama". J Urban Health. 91 (4): 793–808. doi:10.1007/s11524-014-9885-4. PMC 4134449. PMID 24927712.
  14. ↑ Newell, J., et al. "A population-based study of syphilis and sexually transmitted disease syndromes in north-western Tanzania. 2. Risk factors and health seeking behaviour." Genitourinary medicine 69.6 (1993): 421-426.
  15. ↑ 15.0 15.1 Bell MC, Schmidt-Grimminger D, Jacobsen C, Chauhan SC, Maher DM, Buchwald DS (2011). "Risk factors for HPV infection among American Indian and white women in the Northern Plains". Gynecol. Oncol. 121 (3): 532–6. doi:10.1016/j.ygyno.2011.02.032. PMC 4498572. PMID 21414655.
  16. ↑ Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, Markowitz L, Unger ER (2004). "Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population". J. Infect. Dis. 189 (1): 46–50. doi:10.1086/380466. PMID 14702152.
  17. ↑ 17.0 17.1 Koutsky L (1997). "Epidemiology of genital human papillomavirus infection". Am. J. Med. 102 (5A): 3–8. PMID 9217656.
  18. ↑ Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA (2003). "Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students". Am. J. Epidemiol. 157 (3): 218–26. PMID 12543621.
  19. ↑ Tseng CJ, Liang CC, Soong YK, Pao CC (1998). "Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery". Obstet Gynecol. 91 (1): 92–6. PMID 9464728.
  20. ↑ Ting J, Kruzikas DT, Smith JS (2010). "A global review of age-specific and overall prevalence of cervical lesions". Int. J. Gynecol. Cancer. 20 (7): 1244–9. PMID 21495248.
  21. ↑ Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ (1997). "Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?". Cancer Epidemiol. Biomarkers Prev. 6 (10): 799–805. PMID 9332762.
  22. ↑ Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, Manos MM (1991). "Determinants of genital human papillomavirus infection in young women". J. Natl. Cancer Inst. 83 (14): 997–1003. PMID 1649312.
  23. ↑ GENITOURINARY MEDICINE, Volume 72, Number 3: Pages 155-9, June 1996.
  24. ↑ International Journal of Research in Health Sciences. Jan–Mar 2014 Volume-2, Issue-1
  25. ↑ 25.0 25.1 25.2 25.3 Pandya I, Shinojia M, Vadukul D, Marfatia YS (2014). "Approach to balanitis/balanoposthitis: Current guidelines". Indian J Sex Transm Dis. 35 (2): 155–7. doi:10.4103/0253-7184.142415. PMC 4553848. PMID 26396455.
  26. ↑ Edwards S (1996). "Balanitis and balanoposthitis: a review". Genitourin Med. 72 (3): 155–9. PMC 1195642. PMID 8707315.
  27. ↑ Dockerty WG, Sonnex C (1995). "Candidal balano-posthitis: a study of diagnostic methods". Genitourin Med. 71 (6): 407–9. PMC 1196117. PMID 8566986.
  28. ↑ Edwards SK, Bunker CB, Ziller F, van der Meijden WI (2014). "2013 European guideline for the management of balanoposthitis". Int J STD AIDS. 25 (9): 615–26. doi:10.1177/0956462414533099. PMID 24828553.
Retrieved from "https://www.wikidoc.org/index.php?title=Infectious_balanitis&oldid=1292180"